ABSTRACT
Two isomeric Co(II) complexes with the same general molecular formula of [Co(napy)2(NO3)2] (napy = 1,8-naphthyridine) have been synthesized. X-ray single crystal structural determination demonstrates that the two compounds exhibit highly irregular six- (1) and seven-coordinate (2) geometries, respectively. The magnetic measurements, X-band EPR data and theoretical calculations were thoroughly investigated. Both complexes show field-induced slow magnetic relaxation, of which the slow magnetic relaxation in 2 is attributed to an easy-plane anisotropy.
ABSTRACT
Polypyrimidine tract-binding protein 1 (PTBP1) plays an essential role in splicing and is expressed in almost all cell types in humans, unlike the other proteins of the PTBP family. PTBP1 mediates several cellular processes in certain types of cells, including the growth and differentiation of neuronal cells and activation of immune cells. Its function is regulated by various molecules, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and RNA-binding proteins. PTBP1 plays roles in various diseases, particularly in some cancers, including colorectal cancer, renal cell cancer, breast cancer, and glioma. In cancers, it acts mainly as a regulator of glycolysis, apoptosis, proliferation, tumorigenesis, invasion, and migration. The role of PTBP1 in cancer has become a popular research topic in recent years, and this research has contributed greatly to the formulation of a useful therapeutic strategy for cancer. In this review, we summarize recent findings related to PTBP1 and discuss how it regulates the development of cancer cells.
Subject(s)
Alternative Splicing , Carcinogenesis , Glycolysis , Heterogeneous-Nuclear Ribonucleoproteins/physiology , Polypyrimidine Tract-Binding Protein/physiology , Heterogeneous-Nuclear Ribonucleoproteins/chemistry , Humans , MicroRNAs/physiology , Neoplasms/genetics , Neoplasms/metabolism , Neoplasms/pathology , Polypyrimidine Tract-Binding Protein/chemistry , RNA, Long Noncoding/physiologyABSTRACT
Metastasis of nasopharyngeal carcinoma (NPC) remains a main cause of death for NPC patients even though great advances have been made in therapeutic approaches. An in-depth study into the molecular mechanisms of NPC metastasis will help us combat NPC. Epstein-Barr virus (EBV) infection is an evident feature of nonkeratinizing NPC and is strongly associated with tumor metastasis. Recently, long noncoding RNAs (lncRNAs) and microRNAs (miRNAs) have become a hot topic of research due to their epigenetic regulatory roles in NPC metastasis. The EBV products, lncRNAs and miRNAs can target each other and share several common signaling pathways, which form an interconnected, complex molecular regulatory network. In this review, we discuss the features of this regulatory network and summarize the molecular mechanisms of NPC metastasis, focusing on EBV, lncRNAs and miRNAs with updated knowledge.
ABSTRACT
Clinical research methods have been rapidly developing, and the design of clinical trials including traditional Chinese medicine is advancing. To a certain extent, all of these ensure that the results of clinical research are objective and scientific, but whether these results and the resulting guidelines or consensus have much practical significance on clinical practice is still controversial. The authors engage in both clinical practice and clinical research; they strongly feel that it is necessary to discuss the relationship between clinical trials and clinical practice. This essay discusses this relationship in four parts.
